Skip to Content

Notice

Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID)

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee:

Time and Date: 3:00-4:00 p.m. Eastern Time, March 14, 2013.

Place: Teleconference.

Status: The meeting is open to the public; the toll free dial in number is 1-877-951-7311 with a passcode of 6420598.

Purpose: The BSC, OID, provides advice and guidance to the Secretary, Department of Health and Human Services; the Director, CDC; the Director, OID; and the Directors of the National Center for Immunization and Respiratory Diseases, the National Center for Emerging and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: strategies, goals, and priorities for programs; research within the national centers; and overall strategic direction and focus of OID and the national centers.

Matters To Be Discussed: The purpose of the meeting is to discuss the potential for forming an infectious disease laboratory working group under the BSC, OID.

The agenda and any supplemental material will be available at www.cdc.gov/​oid/​BSC.html after March 1.

Agenda items are subject to change as priorities dictate.

Contact Person for More Information: Robin Moseley, M.A.T., Designated Federal Officer, OID, CDC, 1600 Clifton Road NE., Mailstop D10, Atlanta, Georgia 30333, Telephone: (404) 639-4461.

The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Start Signature

Elaine L. Baker,

Director, Management Analysis and Services Office Centers for Disease Control and Prevention.

End Signature End Preamble

[FR Doc. 2013-03610 Filed 2-15-13; 8:45 am]

BILLING CODE 4163-18-P